Walleye Trading LLC Ligand Pharmaceuticals Inc Transaction History

Walleye Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $7,769 - $9,592	132 New	132 $7,000
Q2 2022 Aug 08, 2022	SELL	$74.52 - $117.06 $172,290 - $270,642	-2,312 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $177,441 - $283,114	1,868 Added 420.72%	2,312 $260,000
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $56,991 - $120,825	444 New	444 $60,000

249

17.7M

61K

7.8K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.91B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.